Telocyte
Michelle Hylan is the Founder and CEO of Innov8tive Research Consulting. Michelle also serves as the Chief Operating Officer at Telocyte. With extensive experience as a Clinical Consultant at various pharmaceutical companies such as Rhythm Pharmaceuticals Inc., Regenacy Pharmaceuticals LLC, HemoShear Therapeutics, and Allena Pharmaceuticals, Inc. Michelle has also been a Principal Consultant at Halloran Consulting Group, Inc., Novartis Vaccines and Diagnostics, and Shire HGT. Michelle received their education from Wellesley College and Connecticut College.
This person is not in any teams
Telocyte
We are a biotechnology company dedicated to curing Alzheimer's disease. We are planning FDA-sponsored human trials, using telomerase therapy to reset cell aging within the central nervous system. We believe that Alzheimer's disease can stopped, prevented, and cured.